GASTROENTERITIS ESCHERICHIA COLI

Clinical trials for GASTROENTERITIS ESCHERICHIA COLI explained in plain language.

Never miss a new study

Get alerted when new GASTROENTERITIS ESCHERICHIA COLI trials appear

Sign up with your email to follow new studies for GASTROENTERITIS ESCHERICHIA COLI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First human test of new oral e. coli vaccine

⭐️ VACCINE ⭐️ Completed

This early-stage study tested a new oral vaccine designed to prevent diarrhea caused by harmful E. coli bacteria, a common problem for travelers and children in developing countries. Researchers gave 36 healthy adults different doses of the experimental vaccine to check if it was…

Matched conditions: GASTROENTERITIS ESCHERICHIA COLI

Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 24, 2026 12:10 UTC

GASTROENTERITIS ESCHERICHIA COLI

Get alerted when new GASTROENTERITIS ESCHERICHIA COLI trials appear

First human test of new oral e. coli vaccine